• Education
    • Higher Education
    • Scholarships & Grants
    • Online Learning
    • School Reforms
    • Research & Innovation
  • Lifestyle
    • Travel
    • Food & Drink
    • Fashion & Beauty
    • Home & Living
    • Relationships & Family
  • Technology & Startups
    • Software & Apps
    • Startup Success Stories
    • Startups & Innovations
    • Tech Regulations
    • Venture Capital
    • Artificial Intelligence
    • Cybersecurity
    • Emerging Technologies
    • Gadgets & Devices
    • Industry Analysis
  • About us
  • Contact
  • Advertise with Us
  • Privacy & Policy
Today Headline
  • Home
  • World News
    • Us & Canada
    • Europe
    • Asia
    • Africa
    • Middle East
  • Politics
    • Elections
    • Political Parties
    • Government Policies
    • International Relations
    • Legislative News
  • Business & Finance
    • Market Trends
    • Stock Market
    • Entrepreneurship
    • Corporate News
    • Economic Policies
  • Science & Environment
    • Space Exploration
    • Climate Change
    • Wildlife & Conservation
    • Environmental Policies
    • Medical Research
  • Health
    • Public Health
    • Mental Health
    • Medical Breakthroughs
    • Fitness & Nutrition
    • Pandemic Updates
  • Sports
    • Football
    • Basketball
    • Tennis
    • Olympics
    • Motorsport
  • Entertainment
    • Movies
    • Music
    • TV & Streaming
    • Celebrity News
    • Awards & Festivals
  • Crime & Justice
    • Court Cases
    • Cybercrime
    • Policing
    • Criminal Investigations
    • Legal Reforms
No Result
View All Result
  • Home
  • World News
    • Us & Canada
    • Europe
    • Asia
    • Africa
    • Middle East
  • Politics
    • Elections
    • Political Parties
    • Government Policies
    • International Relations
    • Legislative News
  • Business & Finance
    • Market Trends
    • Stock Market
    • Entrepreneurship
    • Corporate News
    • Economic Policies
  • Science & Environment
    • Space Exploration
    • Climate Change
    • Wildlife & Conservation
    • Environmental Policies
    • Medical Research
  • Health
    • Public Health
    • Mental Health
    • Medical Breakthroughs
    • Fitness & Nutrition
    • Pandemic Updates
  • Sports
    • Football
    • Basketball
    • Tennis
    • Olympics
    • Motorsport
  • Entertainment
    • Movies
    • Music
    • TV & Streaming
    • Celebrity News
    • Awards & Festivals
  • Crime & Justice
    • Court Cases
    • Cybercrime
    • Policing
    • Criminal Investigations
    • Legal Reforms
No Result
View All Result
Today Headline
No Result
View All Result
Home Science & Environment Medical Research

DoxyPEP use linked to sharp decline in STI cases

January 6, 2025
in Medical Research
Reading Time: 3 mins read
A A
0
pill
6
SHARES
14
VIEWS
Share on FacebookShare on Twitter


pill
Credit: CC0 Public Domain

A new study has found that rates of chlamydia and syphilis plummet among people prescribed doxycycline for sexually transmitted infection prevention in routine clinical care.

The study was led by the Harvard Pilgrim Health Care Institute with collaborators from Kaiser Permanente Northern California, Kaiser Permanente Mid-Atlantic States, and Kaiser Permanente Georgia. It was published on Jan. 6 in JAMA Internal Medicine.

DoxyPEP is a new strategy for preventing STIs that involves taking a dose of doxycycline, a common and well-tolerated antibiotic medication, within 72 hours of sex. Clinical trials have shown that using doxyPEP greatly reduces the risk of acquiring bacterial STIs, particularly chlamydia and syphilis, among people assigned male sex at birth. However, few studies have assessed whether use of doxyPEP reduces STIs when prescribed in routine care.

“Interventions that are effective in clinical trials don’t always end up working in real-world settings, where people tend to face more barriers to consistent medication use,” said Michael Traeger, Ph.D., a research fellow at Harvard Pilgrim Health Care Institute and lead author of the study. “We were excited to see that doxyPEP users in our study experienced declines in chlamydia and syphilis comparable to those observed in clinical trials.”

In October 2022, San Francisco became the first jurisdiction to issue guidelines recommending that doxyPEP be offered to gay and bisexual men and transgender women at risk of STIs. Kaiser Permanente Northern California began offering doxyPEP to people using HIV PrEP, or preexposure prophylaxis, shortly thereafter, in November 2022.

The new study, which examined the largest cohort of doxyPEP recipients reported globally to date, used pharmacy data to determine which HIV PrEP users in Kaiser Permanente Northern California filled prescriptions for doxyPEP. Demand was high: of nearly 12,000 HIV PrEP users, almost one in five—2,253 people—received doxyPEP within its first year of availability. The vast majority of people prescribed doxyPEP were assigned male sex at birth, and doxyPEP users were racially and ethnically similar to the overall population of HIV PrEP users.

The researchers then looked at STI test results before and after doxyPEP initiation to understand how doxyPEP use may have affected risk of acquiring STIs. They found that STI incidence declined by 79% for chlamydia, 80% for syphilis, and 12% for gonorrhea.

“Since we started offering doxyPEP to our patients, our clinicians have seen a marked decline in both positive STI test results and the number of patients needing treatment after an STI exposure,” said study co-author Jonathan Volk, MD, MPH, an infectious disease specialist with The Permanente Medical Group. “But the reduction in gonorrhea in our study was modest, underscoring the importance of regular STI testing for patients using doxyPEP.”

“Rising syphilis rates, including more cases of congenital syphilis, highlight the urgent need for innovative tools like doxyPEP,” added co-author Michael Silverberg, Ph.D., MPH, an HIV epidemiologist with the Kaiser Permanente Division of Research.

“We know there are important questions that still need to be answered about doxyPEP, including its effects on antimicrobial resistance,” said Julia Marcus, Ph.D., Harvard Medical School associate professor of population medicine at the Harvard Pilgrim Health Care Institute and senior author of the study. “In the meantime, our study suggests that broader implementation of doxyPEP could have tremendous benefits for reducing STI transmission and improving sexual health.”

More information:
Doxycycline Postexposure Prophylaxis and Bacterial Sexually Transmitted Infections Among Individuals Using HIV Preexposure Prophylaxis, JAMA Internal Medicine (2025). DOI: 10.1001/jamainternmed.2024.7186

Provided by
Harvard Pilgrim Health Care Institute


Citation:
DoxyPEP use linked to sharp decline in STI cases (2025, January 6)
retrieved 6 January 2025
from https://medicalxpress.com/news/2025-01-doxypep-linked-sharp-decline-sti.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.



pill
Credit: CC0 Public Domain

A new study has found that rates of chlamydia and syphilis plummet among people prescribed doxycycline for sexually transmitted infection prevention in routine clinical care.

The study was led by the Harvard Pilgrim Health Care Institute with collaborators from Kaiser Permanente Northern California, Kaiser Permanente Mid-Atlantic States, and Kaiser Permanente Georgia. It was published on Jan. 6 in JAMA Internal Medicine.

DoxyPEP is a new strategy for preventing STIs that involves taking a dose of doxycycline, a common and well-tolerated antibiotic medication, within 72 hours of sex. Clinical trials have shown that using doxyPEP greatly reduces the risk of acquiring bacterial STIs, particularly chlamydia and syphilis, among people assigned male sex at birth. However, few studies have assessed whether use of doxyPEP reduces STIs when prescribed in routine care.

“Interventions that are effective in clinical trials don’t always end up working in real-world settings, where people tend to face more barriers to consistent medication use,” said Michael Traeger, Ph.D., a research fellow at Harvard Pilgrim Health Care Institute and lead author of the study. “We were excited to see that doxyPEP users in our study experienced declines in chlamydia and syphilis comparable to those observed in clinical trials.”

In October 2022, San Francisco became the first jurisdiction to issue guidelines recommending that doxyPEP be offered to gay and bisexual men and transgender women at risk of STIs. Kaiser Permanente Northern California began offering doxyPEP to people using HIV PrEP, or preexposure prophylaxis, shortly thereafter, in November 2022.

The new study, which examined the largest cohort of doxyPEP recipients reported globally to date, used pharmacy data to determine which HIV PrEP users in Kaiser Permanente Northern California filled prescriptions for doxyPEP. Demand was high: of nearly 12,000 HIV PrEP users, almost one in five—2,253 people—received doxyPEP within its first year of availability. The vast majority of people prescribed doxyPEP were assigned male sex at birth, and doxyPEP users were racially and ethnically similar to the overall population of HIV PrEP users.

The researchers then looked at STI test results before and after doxyPEP initiation to understand how doxyPEP use may have affected risk of acquiring STIs. They found that STI incidence declined by 79% for chlamydia, 80% for syphilis, and 12% for gonorrhea.

“Since we started offering doxyPEP to our patients, our clinicians have seen a marked decline in both positive STI test results and the number of patients needing treatment after an STI exposure,” said study co-author Jonathan Volk, MD, MPH, an infectious disease specialist with The Permanente Medical Group. “But the reduction in gonorrhea in our study was modest, underscoring the importance of regular STI testing for patients using doxyPEP.”

“Rising syphilis rates, including more cases of congenital syphilis, highlight the urgent need for innovative tools like doxyPEP,” added co-author Michael Silverberg, Ph.D., MPH, an HIV epidemiologist with the Kaiser Permanente Division of Research.

“We know there are important questions that still need to be answered about doxyPEP, including its effects on antimicrobial resistance,” said Julia Marcus, Ph.D., Harvard Medical School associate professor of population medicine at the Harvard Pilgrim Health Care Institute and senior author of the study. “In the meantime, our study suggests that broader implementation of doxyPEP could have tremendous benefits for reducing STI transmission and improving sexual health.”

More information:
Doxycycline Postexposure Prophylaxis and Bacterial Sexually Transmitted Infections Among Individuals Using HIV Preexposure Prophylaxis, JAMA Internal Medicine (2025). DOI: 10.1001/jamainternmed.2024.7186

Provided by
Harvard Pilgrim Health Care Institute


Citation:
DoxyPEP use linked to sharp decline in STI cases (2025, January 6)
retrieved 6 January 2025
from https://medicalxpress.com/news/2025-01-doxypep-linked-sharp-decline-sti.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.


Tags: Health ResearchHealth Research NewsHealth ScienceMedicine ResearchMedicine Research NewsMedicine Science
Previous Post

Congress meets to certify Trump’s 2024 election victory

Next Post

SpaceX to launch first dedicated Starlink mission of 2025 – Spaceflight Now

Related Posts

Coreline Soft scores imaging AI supply contracts with UK NHS, Boehringer Ingelheim and more briefs

Coreline Soft scores imaging AI supply contracts with UK NHS, Boehringer Ingelheim and more briefs

May 30, 2025
5
woman on phone call at work

Self-employed women may have significantly lower heart attack risk than salaried counterparts

May 30, 2025
5
Next Post
SpaceX to launch first dedicated Starlink mission of 2025 – Spaceflight Now

SpaceX to launch first dedicated Starlink mission of 2025 – Spaceflight Now

  • Trending
  • Comments
  • Latest
Family calls for change after B.C. nurse dies by suicide after attacks on the job

Family calls for change after B.C. nurse dies by suicide after attacks on the job

April 2, 2025
Pioneering 3D printing project shares successes

Product reduces TPH levels to non-hazardous status

November 27, 2024

Hospital Mergers Fail to Deliver Better Care or Lower Costs, Study Finds todayheadline

December 31, 2024

Police ID man who died after Corso Italia fight

December 23, 2024
Harris tells supporters 'never give up' and urges peaceful transfer of power

Harris tells supporters ‘never give up’ and urges peaceful transfer of power

0
Des Moines Man Accused Of Shooting Ex-Girlfriend's Mother

Des Moines Man Accused Of Shooting Ex-Girlfriend’s Mother

0

Trump ‘looks forward’ to White House meeting with Biden

0
Catholic voters were critical to Donald Trump’s blowout victory: ‘Harris snubbed us’

Catholic voters were critical to Donald Trump’s blowout victory: ‘Harris snubbed us’

0
ET logo

RBSE 5th class result 2025: Check how to download the marksheet from rajshaladarpan.nic.in by roll number, alternate sites todayheadline

May 30, 2025
Rough Weather, Rolling Waves, and a Change of Plans at Sea

Rough Weather, Rolling Waves, and a Change of Plans at Sea

May 30, 2025
Coreline Soft scores imaging AI supply contracts with UK NHS, Boehringer Ingelheim and more briefs

Coreline Soft scores imaging AI supply contracts with UK NHS, Boehringer Ingelheim and more briefs

May 30, 2025
U.S.-China talks 'a bit stalled' and need Trump and Xi to weigh in, Treasury Secretary Bessent says

U.S.-China talks ‘a bit stalled’ and need Trump and Xi to weigh in, Treasury Secretary Bessent says

May 30, 2025

Recent News

ET logo

RBSE 5th class result 2025: Check how to download the marksheet from rajshaladarpan.nic.in by roll number, alternate sites todayheadline

May 30, 2025
0
Rough Weather, Rolling Waves, and a Change of Plans at Sea

Rough Weather, Rolling Waves, and a Change of Plans at Sea

May 30, 2025
3
Coreline Soft scores imaging AI supply contracts with UK NHS, Boehringer Ingelheim and more briefs

Coreline Soft scores imaging AI supply contracts with UK NHS, Boehringer Ingelheim and more briefs

May 30, 2025
5
U.S.-China talks 'a bit stalled' and need Trump and Xi to weigh in, Treasury Secretary Bessent says

U.S.-China talks ‘a bit stalled’ and need Trump and Xi to weigh in, Treasury Secretary Bessent says

May 30, 2025
2

TodayHeadline is a dynamic news website dedicated to delivering up-to-date and comprehensive news coverage from around the globe.

Follow Us

Browse by Category

  • Africa
  • Asia
  • Basketball
  • Business & Finance
  • Climate Change
  • Crime & Justice
  • Cybersecurity
  • Economic Policies
  • Elections
  • Entertainment
  • Entrepreneurship
  • Environmental Policies
  • Europe
  • Football
  • Gadgets & Devices
  • Health
  • Medical Research
  • Mental Health
  • Middle East
  • Motorsport
  • Olympics
  • Politics
  • Public Health
  • Relationships & Family
  • Science & Environment
  • Software & Apps
  • Space Exploration
  • Sports
  • Stock Market
  • Technology & Startups
  • Tennis
  • Travel
  • Uncategorized
  • Us & Canada
  • Wildlife & Conservation
  • World News

Recent News

ET logo

RBSE 5th class result 2025: Check how to download the marksheet from rajshaladarpan.nic.in by roll number, alternate sites todayheadline

May 30, 2025
Rough Weather, Rolling Waves, and a Change of Plans at Sea

Rough Weather, Rolling Waves, and a Change of Plans at Sea

May 30, 2025
  • Education
  • Lifestyle
  • Technology & Startups
  • About us
  • Contact
  • Advertise with Us
  • Privacy & Policy

© 2024 Todayheadline.co

Welcome Back!

OR

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Business & Finance
  • Corporate News
  • Economic Policies
  • Entrepreneurship
  • Market Trends
  • Crime & Justice
  • Court Cases
  • Criminal Investigations
  • Cybercrime
  • Legal Reforms
  • Policing
  • Education
  • Higher Education
  • Online Learning
  • Entertainment
  • Awards & Festivals
  • Celebrity News
  • Movies
  • Music
  • Health
  • Fitness & Nutrition
  • Medical Breakthroughs
  • Mental Health
  • Pandemic Updates
  • Lifestyle
  • Fashion & Beauty
  • Food & Drink
  • Home & Living
  • Politics
  • Elections
  • Government Policies
  • International Relations
  • Legislative News
  • Political Parties
  • Africa
  • Asia
  • Europe
  • Middle East
  • Artificial Intelligence
  • Cybersecurity
  • Emerging Technologies
  • Gadgets & Devices
  • Industry Analysis
  • Basketball
  • Football
  • Motorsport
  • Olympics
  • Climate Change
  • Environmental Policies
  • Medical Research
  • Science & Environment
  • Space Exploration
  • Wildlife & Conservation
  • Sports
  • Tennis
  • Technology & Startups
  • Software & Apps
  • Startup Success Stories
  • Startups & Innovations
  • Tech Regulations
  • Venture Capital
  • Uncategorized
  • World News
  • Us & Canada
  • Public Health
  • Relationships & Family
  • Travel
  • Research & Innovation
  • Scholarships & Grants
  • School Reforms
  • Stock Market
  • TV & Streaming
  • Advertise with Us
  • Privacy & Policy
  • About us
  • Contact

© 2024 Todayheadline.co